MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-06-0006239
Coax Bioremedies Private Limited
Coax Bioremedies Private Limited - pharma in Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹15.08 Cr
▲ 33% YoY
Net profit · FY 2025
₹32.89 Lakh
Net margin 2.2%
EBITDA · FY 2025
₹61.17 Lakh
EBITDA margin 4.1%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹1.04 Cr
Satisfied ₹68 Lakh
Company age
24 yrs
Est. 2002
Employees · EPFO
53
Provident fund records
About Coax Bioremedies Private Limited
Data last updated:
Coax Bioremedies Private Limited is a private limited company based in Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 December 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397HR2002PTC035005. Its GSTIN is 06AACCC1615L1ZW (Haryana).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1 Cr. It is led by directors Harsh Vasudeva and Atam Parkash Vasudeva.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 83 Sector – 27 – 28 Hisar, Haryana, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.08 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹32.89 Lakh (net margin 2.2%) and EBITDA of ₹61.17 Lakh (EBITDA margin 4.1%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 19% over five years.
The company has about 53 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.04 Cr and satisfied charges of ₹68 Lakh on record. Court records list 7 cases involving the company, including 3 filed by the company and 4 filed against it; 4 cases are pending.
Coax Bioremedies Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-06-0006239). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51397HR2002PTC035005
Registration Number 035005
Incorporation Date 09 December 2002
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-06-0006239
Recognitions & Rankings of Coax Bioremedies
Contact details
Coax Bioremedies Private Limited's registered office is in Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address83 Sector – 27 – 28 Hisar, Haryana, India
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Coax Bioremedies Private Limited, buy the company report.
Comprehensive company report
Coax Bioremedies Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Coax Bioremedies is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Coax Bioremedies Private Limited, buy the company report.
Financials of Coax Bioremedies Private Limited
FY 2025 filings availableCoax Bioremedies Private Limited reported revenue of ₹15.08 Cr (up 33% YoY) for FY 2025.
Revenue · FY 2025
₹15.08 Cr ▲ 33%
Net profit · FY 2025
₹32.89 Lakh margin 2.2%
EBITDA · FY 2025
₹61.17 Lakh margin 4.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 33%
3 years · compounded
▲ 7%
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▲ 91%
3 years · compounded
▼ 10%
5 years · compounded
▲ 13%
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 33% growth in the latest year. EBITDA rose 91% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹61.17 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹32.89 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.1% | ||||
| Net Profit Margin | 2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Coax Bioremedies Private Limited, buy the company report.
Board of directors of Coax Bioremedies Private Limited
Coax Bioremedies has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harsh Vasudeva | Director | 21 Sep 2009 | 17 Years 1 Months | Current |
| Atam Parkash Vasudeva | Director | 09 Dec 2002 | 23 Years 11 Months | Current |
Peer comparison
Coax Bioremedies Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nicosia Biolabs International Private Limited | ₹15.16 Cr (FY 2024) | 66.0% | Ludhiana, Punjab, India | |||
| Eumark Pharmaceuticals Pvt Ltd | ₹15.13 Cr (FY 2025) | 16.0% | Ambernath, Maharashtra, India | |||
| Arco Pharma Private Limited | ₹15.11 Cr (FY 2025) | 0.0% | Mumbai, Maharashtra, India | |||
| Coax Bioremedies Private Limitedthis company | ₹15.08 Cr (FY 2025) | ₹32.89 Lakh | 2.2% | 33.0% | 53 | Haryana, India |
| Kras Pharmaceuticals Private Limited | ₹15.05 Cr (FY 2025) | 45.0% | Fatuha, Bihar, India | |||
| Kansas Laboratories Pvt Ltd | ₹15.04 Cr (FY 2025) | 13.0% | Kolkata, West Bengal, India | |||
| Grindlays Pharmaceuticals Pvt Ltd | ₹14.96 Cr (FY 2025) | 69.0% | Mumbai, Maharashtra, India | |||
| Santexo Pharma Private Limited | ₹14.95 Cr (FY 2025) | 86.0% | New Delhi, Delhi, India |
To see the full peer comparison of Coax Bioremedies Private Limited, buy the company report.
Auditor
Coax Bioremedies Private Limited is audited by KULDIP KHERA & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KULDIP KHERA & CO | FY 2024 | 080670 |
Shareholding
The shareholding of Coax Bioremedies Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Coax Bioremedies Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.04 Cr
Satisfied charges
₹68 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Nov 2019 | 100309414 | Others | ₹9 Lakh | Open | |
| 18 Nov 2003 | 80063673 | Others | ₹95 Lakh | Open | |
| 18 Dec 2003 | 90050264 | Punjab National Bank | ₹23 Lakh | Satisfied | |
| 18 Nov 2003 | 90050186 | Punjab National Bank | ₹41.65 Lakh | Satisfied | |
| 18 Nov 2003 | 80001247 | Punjab National Bank | ₹3.35 Lakh | Satisfied |
To see the full charge records of Coax Bioremedies Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Coax Bioremedies Private Limited has 7 court cases on record: 3 filed by Coax Bioremedies, 4 filed against it. 4 cases are pending and 3 are disposed.
Total cases
7
Filed by the company
3
Filed against the company
4
Pending
4
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 4 | 2 |
| High courts | 2 | 0 | 2 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hisar, Haryana | Court case (N ACT) | Filed by the company against M/S B S P Healthcare | Pending |
| High Court of Andhra Pradesh | Court case (CRLP) | Filed by the company against an individual | Pending |
| High Court of Andhra Pradesh | Court case (CRLP) | Filed by the company against an individual | Pending |
| District court, East Godavari, Andhra Pradesh | Court case (PRC) | Filed against the company by The State of Andhra Pradesh Rep.By the Drug Inspector, Amalapuram, E.G.Dt. | Pending |
| District court, Faridkot, Punjab | Criminal case | Filed against the company by State Through Drugs Inspector Faridkot | Disposed |
To see the full case history of Coax Bioremedies Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Coax Bioremedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Coax Bioremedies Private Limited has a workforce of 53 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
53
Active EPFO establishments
1
Employee growth
1.9%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 53 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Coax Bioremedies Private Limited, buy the company report.
GST
Coax Bioremedies has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AACCC1615L1ZW | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Coax Bioremedies Private Limited, buy the company report.
Recent activity
Coax Bioremedies Private Limited has 3 board changes on record since 2002: 2 appointments and 1 cessation. The latest: Harsh Vasudeva was appointed as Director on 21 Sep 2009.
AGM
Coax Bioremedies Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Coax Bioremedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 0.09 Cr with Charge ID 100309414 was registered on 26 Nov 2019.
Charges
A charge with Others of Rs. 0.95 Cr registered on 18 Nov 2003 with Charge ID 80063673 was modified on 20 Dec 2018.
Charges
A charge registered on 18 Dec 2003 via Charge ID 90050264 with Punjab National Bank was fully satisfied on 19 Feb 2016.
Charges
A charge registered on 18 Nov 2003 via Charge ID 90050186 with Punjab National Bank was fully satisfied on 19 Feb 2016.
Charges
A charge registered on 18 Nov 2003 via Charge ID 80001247 with Punjab National Bank was fully satisfied on 19 Feb 2016.
Appointed
Harsh Vasudeva was appointed as Director.
Ceased
Subhash Chand ceased to be Director.
Charges
A charge with Punjab National Bank of Rs. 0.23 Cr registered on 18 Dec 2003 with Charge ID 90050264 was modified on 31 Mar 2006.
Charges
A charge with Punjab National Bank of Rs. 0.42 Cr registered on 18 Nov 2003 with Charge ID 90050186 was modified on 31 Mar 2006.
Charges
A charge with Punjab National Bank of Rs. 0.03 Cr registered on 18 Nov 2003 with Charge ID 80001247 was modified on 31 Mar 2006.
6 earlier events are in the company report.
Frequently asked questions
Coax Bioremedies is an active private limited company based in Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 December 2002 (24+ years old) and is registered under CIN U51397HR2002PTC035005.
Coax Bioremedies has 2 current directors:
- Harsh Vasudeva - Director
- Atam Parkash Vasudeva - Director
The latest financial statements of Coax Bioremedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Coax Bioremedies is 06AACCC1615L1ZW, registered in Haryana.
The CIN (Corporate Identification Number) of Coax Bioremedies is U51397HR2002PTC035005. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Coax Bioremedies has 7 court cases on record: 3 filed by the company and 4 filed against it. 4 are pending. Most are in the district courts.
Coax Bioremedies was incorporated on 09 December 2002, making it 24+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Coax Bioremedies by revenue are Nicosia Biolabs International Private Limited, Eumark Pharmaceuticals Pvt Ltd, Arco Pharma Private Limited, Kras Pharmaceuticals Private Limited, Kansas Laboratories Pvt Ltd and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Harsh Vasudeva was appointed as Director on 21 Sep 2009. Subhash Chand ceased to be Director on 21 Sep 2009. Atam Parkash Vasudeva was appointed as Director on 09 Dec 2002.
Yes, Coax Bioremedies is registered as a small enterprise under Udyam registration (number: UDYAM-HR-06-0006239).
The registered office of Coax Bioremedies is at 83 Sector – 27 – 28 Hisar, Haryana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages